YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Most cancer cells are exposed to altered extracellular environments, such as an increase in extracellular matrix (ECM) stiffness and soluble signals consisting of growth factors and cytokines. It is therefore conceivable that changes in tumor extracellular environments affect tumor cell behavior. The Hippo pathway reportedly responds to the extracellular environment and regulates the nuclear localization of the transcription co‐activator, yes‐associated protein (YAP)/transcriptional co‐activator with PDZ‐binding motif (TAZ). Inactivation of the Hippo pathway with nuclear translocation of YAP/TAZ stimulates cell proliferation. Its pathway also regulates gene expression, but the precise molecule(s) meditating the cell‐proliferating effect of YAP signaling on oral squamous cell carcinoma (OSCC) is unclear. First, we examined the effects of YAP signaling on OSCC tumorigenesis. Loss‐of‐function experiments using siRNA or an inhibitor, and immunohistochemical analyses of tissue specimens obtained from OSCC patients demonstrated that YAP signaling was involved in OSCC cell proliferation. Second, we identified Piezo‐type mechanosensitive ion channel component 1 (PIEZO1), a Ca 2+ channel, as a transcriptional target of YAP signaling and showed that elevated PIEZO1 was required for PIEZO1 agonist‐dependent Ca 2+ entry and cell proliferation in OSCC cells. Experiments using three‐dimensional and suspension culture revealed that PIEZO1 was involved in OSCC cellular growth. Finally, YAP overexpression in the nucleus and/or cytoplasm was immunohistochemically detected in tumor lesions with frequent expression of both PIEZO1 and Ki‐67, but not in non‐tumor regions of OSCC specimens. These results suggest that the YAP/PIEZO1 axis promotes OSCC cell growth. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channels
Coste, B., Mathur, J., Schmidt, M., Earley, T. J., Ranade, S., Petrus, M. J., Dubin, A. E., & Patapoutian, A. (2010) · Science · doi:10.1126/science.1193270 · Cited by 3,316 · cited 2×
“Piezo-type mechanosensitive ion channel component (PIEZO) channels, including PIEZO1 and PIEZO2, were identified as mechanically activated ion channels [18].”
BackgroundMAPK signal pathways in the regulation of cell proliferation in mammalian cells
ZHANG, W., & LIU, H. T. (2002) · Cell Research · doi:10.1038/sj.cr.7290105 · Cited by 2,845 · cited 1×
“As ERK1/2 and p38 MAPK activation are involved in cell proliferation [52,53], the effect of PIEZO1 on cell proliferation was examined in OSCC cells.”
BackgroundGenome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2015) · Nature Cell Biology · doi:10.1038/ncb3216 · Cited by 1,219
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Varelas, X. (2014) · Development · doi:10.1242/dev.102376 · Cited by 665 · cited 1×
“We searched for putative binding sites of TEA domain transcription factor 4 (TEAD4), a major transcription factor in the Hippo pathway regulating transcriptional targets associated with YAP/TAZ [46], using the Cistrome Data Browser database Table 2.”
MethodStretch-activated ion channel Piezo1 directs lineage choice in human neural stem cells
Pathak, M. M., Nourse, J. L., Tran, T., Hwe, J., Arulmoli, J., Le, D. T. T., Bernardis, E., Flanagan, L. A., & Tombola, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409802111 · Cited by 657
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
Force-induced conformational changes in PIEZO1
Lin, Y.-C., Guo, Y. R., Miyagi, A., Levring, J., MacKinnon, R., & Scheuring, S. (2019) · Nature · doi:10.1038/s41586-019-1499-2 · Cited by 433 · cited 1×
“Cryo-electron microscopy and high-speed atomic force microscopy showed that PIEZO1 structural deformation gates its channel in response to mechanical stress [54], thereby inducing Ca influx [55].”
Background
Cited by
The Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Jiang, Y., Zhang, H., Wang, J., Liu, Y., Luo, T., & Hua, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01252-0 · Cited by 491
Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Li, Q., Tie, Y., Alu, A., Ma, X., & Shi, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01297-0 · Cited by 253
Tang, H., Zeng, R., He, E., Zhang, I., Ding, C., & Zhang, A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00085 · Cited by 120
Liu, S., Xu, X., Fang, Z., Ning, Y., Deng, B., Pan, X., He, Y., Yang, Z., Huang, K., & Li, J. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102367 · Cited by 104
Piezo1 and its inhibitors: Overview and perspectives
Thien, N. D., Hai-Nam, N., Anh, D. T., & Baecker, D. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116502 · Cited by 85
Li, Y.-M., Xu, C., Sun, B., Zhong, F.-J., Cao, M., & Yang, L.-Y. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02574-2 · Cited by 52
Meng, X., Zhu, Y., Tan, H., Daraqel, B., Ming, Y., Li, X., Yang, G., He, X., Song, J., & Zheng, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03884-0 · Cited by 26
Fang, C., Liu, S., Zhang, S., Zheng, H., Fang, G., Chen, C., Zhang, Y., Yao, R., Chen, X., Luo, R., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156908 · Cited by 8
Metadata
- Authors
- Hasegawa, K., Fujii, S., Matsumoto, S., Tajiri, Y., Kikuchi, A., & Kiyoshima, T.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2020-11-05
- Volume
- 253
- Issue
- 1
- Pages
- 80-93
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W3088497047
- Cited by
- 189
- References
- 20
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.